🦊/People

Somu Subramaniam

Investor

Co-founder and Managing Partner at New Science Ventures · Board director at ABL Space Systems · Board director at Glydways · Board director at Alexar Therapeutics

Greater Stockholm Metropolitan Area

Find your path to Somu

20 people in our graph share verified history with Somu — schools, employers, funds. One of them is your warm intro.

Lloyd AppelunlockedSomu: together at New Science Ventures
Somu: together at Glydways
×4Somu: together at ABL Space Systems
×6Somu: together at New Science Ventures

About

Somu Subramaniam co-founded New Science Ventures, where he is Managing Partner. Before starting the firm, he was a director at McKinsey & Company, advising companies across pharmaceuticals, medical devices, biotechnology, photonics, software, and semiconductors, and led parts of its Strategy, Technology, and Healthcare practices while serving on its Investment Committee. He holds a B.Tech. from the Indian Institute of Technology and an M.B.A. from Harvard Business School.

Contact· self-published, not guessed

Invests in

BiotechDeep TechMedical DevicesSemiconductors

Board director at ABL Space Systems

Intro paths

In turn, Somu can intro founders to ABL Space Systems's investors below.

Co-founders at ABL Space Systems

HO
Harrison O'HanleyChief Executive Officer
DP
Daniel PiemontChief Financial Officer, President and Secretary

Board director at Glydways

Intro paths

In turn, Somu can intro founders to Glydways's investors below.

Co-founders at Glydways

MSMark Seeger
Mark SeegerCo-CEO, Founder
ZZZach Zeliff
Zach ZeliffCo-Founder, Chief Product Solutions

Board director at Alexar Therapeutics

Intro paths

In turn, Somu can intro founders to Alexar Therapeutics's investors below.

Co-founders at Alexar Therapeutics

RM
Raju MohanExecutive Officer

Experience

  1. New Science VenturesManaging Partner

Deals · 3

FerricBoard seat

via New Science Ventures · filed Dec 2024 · $50.9M raise

ABL Space SystemsBoard seat

via New Science Ventures · filed Dec 2023 · $100M raise

Vascular TherapiesBoard seat

via New Science Ventures · filed Mar 2022 · $25.2M raise

Attribution from SEC filings, press coverage, and firm rosters.

Other disclosed investments

Board seats

Achronix Semiconductor CorporationAkarna TherapeuticsAntevia NetworksAvari WirelessBioVexCeption TherapeuticsDezima PharmaFerric, IncGlydways, IncK2MLightwireLong WallPakal TechParagraf - companyResolve TherapeuticsVentyx Biosciences, IncVimalan Biosciences, Inc

Sources: SEC Form D filings · the firm's website.

Colleagues at New Science Ventures

Frequently asked questions

Who is Somu Subramaniam?
Somu Subramaniam co-founded New Science Ventures, where he is Managing Partner. Before starting the firm, he was a director at McKinsey & Company, advising companies across pharmaceuticals, medical devices, biotechnology, photonics, software, and semiconductors, and led parts of its Strategy, Technology, and Healthcare practices while serving on its Investment Committee. He holds a B.Tech. from the Indian Institute of Technology and an M.B.A. from Harvard Business School.
Where does Somu Subramaniam work?
Somu Subramaniam is Co-founder and Managing Partner at New Science Ventures and Board director at ABL Space Systems and Board director at Glydways and Board director at Alexar Therapeutics.
What does Somu Subramaniam invest in?
Somu Subramaniam invests in Biotech, Deep Tech, Medical Devices, Semiconductors.
What boards does Somu Subramaniam sit on?
Somu Subramaniam holds tracked board seats at ABL Space Systems, Achronix Semiconductor Corporation, Akarna Therapeutics, Antevia Networks, Avari Wireless, BioVex, Ception Therapeutics, Dezima Pharma, Ferric, Ferric, Inc.

Shared employers